Kimia Biosciences (BOM:530313) Long-Term Capital Lease Obligation : ₹0.00 Mil (As of . 20)

View and export this data going back to 2017. Start your Free Trial

What is Kimia Biosciences Long-Term Capital Lease Obligation?

Kimia Biosciences's Long-Term Capital Lease Obligation for the quarter that ended in . 20 was ₹0.00 Mil.

Kimia Biosciences Long-Term Capital Lease Obligation Historical Data

The historical data trend for Kimia Biosciences's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kimia Biosciences Long-Term Capital Lease Obligation Chart

Kimia Biosciences Annual Data

Trend

Long-Term Capital Lease Obligation

Kimia Biosciences Semi-Annual Data

Long-Term Capital Lease Obligation

Kimia Biosciences (BOM:530313) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Kimia Biosciences Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Kimia Biosciences's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Kimia Biosciences (BOM:530313) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kimia Biosciences Ltd (BOM:530313) » Definitions » Long-Term Capital Lease Obligation

Traded in Other Exchanges

N/A

Address

Netaji Subhash Place, 974, 9th Floor, Aggarwal Millenium Tower-II, Pitampura, New Delhi, IND, 110 034

Website

https://www.kimiabiosciences.com

Kimia Biosciences Ltd is a company engaged in the manufacturing of bulk drugs. Some of the company's products include Azelnidipine, Deflazacort, Oxaceprol, Seratodast, and Tretinoin among others. Its only operating segment being Pharmaceuticals.

Kimia Biosciences (BOM:530313) Headlines

No Headlines